Hexarelin
Hexarelin is a growth hormone secretagogues peptide that has gained attention for its potential health benefits. Research suggests it may help with HGH release and cardioprotection.
Mechanisms of Action
Hexarelin is listed as a growth hormone secretagogues peptide with mechanisms including Ghrelin mimetic. Its current research status is Phase 2, and its Australian access status is Script Required.
Potential Benefits
The potential benefits listed for Hexarelin include HGH release, cardioprotection. These are educational research summaries, not treatment claims or personal medical advice.
- HGH release
- cardioprotection
Potential Side Effects
Possible side effects reported for Hexarelin include cortisol increase, desensitization. Safety, suitability, and medication interactions should be assessed by a qualified clinician.
Frequently Asked Questions
What is Hexarelin?
Hexarelin is a growth hormone secretagogues peptide listed with mechanisms including Ghrelin mimetic. Current research status: Phase 2.
Is Hexarelin legal in Australia?
In Australia, Hexarelin is classified as: Script Required. Access and use should be checked against current Australian regulation and clinician guidance.
What dosage information is listed for Hexarelin?
The dosage field in this educational database lists 205mcg daily. This is not a dosing recommendation; suitability and dosing require medical supervision.
Sources and clinical context
Varney Health frames peptide pages as educational research guides, not prescribing advice. Current Australian access, safety, and suitability should be checked with an AHPRA-registered clinician.
Important Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any peptide therapy. Peptides may have different effects on different individuals and may interact with medications.